Dr. Amy McCoy’s first real exposure to research came from her own hospital bed — on bed rest with a preeclampsia diagnosis during her pregnancy, when a gynecologic oncologist in her training program pulled her onto a research project and taught her grants and study design. Years later, research found her again through pregnancy, this … Read more
Justin brings more than two decades of experience as a healthcare operator, with a track record of scaling multisite services businesses and delivering strong outcomes for investors Paul Evans continues as Chair of the Board to support Velocity’s growth strategy as it enters its next phase The appointment reinforces Velocity’s mission to improve the clinical … Read more
Full network expansion to all studies at 70+ global locations follows a year-long collaboration that improved show-rates by up to 9 percentage points across nearly 100k scheduled screenings. Today, we are excited to announce that Velocity Clinical Research, the world’s largest organization of fully owned and integrated clinical research sites, is deepening its aligned partnership … Read more
By Nick Spittal, Chief Operations Officer, Velocity Clinical Research Most sponsors and CROs talk about slow sites, hard-to-find patients, and protocol complexity putting their studies at risk. Those issues are all real, and they frequently share the same underlying cause: the disparate operating model used across individual study sites. In my experience, study risk often … Read more
Velocity Clinical Research, the world’s largest integrated global site network, today announced that its centralized Electronic Data Capture (EDC) model is now entering 97% of clinical trial data within one business day of patient visits — two to four days faster than the industry average of five days reported in independent benchmarking studies. Additionally, data … Read more
When a large-scale vaccine trial needed to move fast, Velocity delivered — not once, but twice, across two continents. In the United States, Velocity was the sole site network selected to enroll participants for the trial. Across just 10 sites, the team enrolled 1,000 participants in 3.5 weeks. That’s the kind of speed that only … Read more
There is a phrase William Beacham, MD reaches for when people ask how he ended up an OB-GYN: congenital gynecologist. It was his father’s speciality, too, and his grandfather was a physician. Four of his father’s five brothers also went into medicine. So, by the time Dr. Beacham was making his own choices, there was … Read more
Congratulations to Zydus Therapeutics on the US FDA granting Priority Review to their New Drug Application for saroglitazar for the treatment of Primary Biliary Cholangitis (PBC)! Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG — Velocity Principal Investigator and EPICS-III Study Investigator — was featured in the Zydus Therapeutics announcement highlighting the Phase 3 results of … Read more
Given his time again, Robert Buynak, MD, FACP, may well be a train driver — but as a young man, he wasn’t sure how to go about it. Academically gifted, he was raised in the true spirit of the American Dream: “My mom’s family really pushed academics,” he recalls. His mother, born in Croatia during … Read more
Shishir Khetan, MD has always been interested in science and how the body works. His mother was an OB-GYN and, while she never practiced in the U.S., would talk about medicine here and there — a discourse that helped influence his own interest. “My first real interaction with anything medical was volunteering at a local … Read more